Understanding the pharmacokinetics of anxiolytic drugs.

@article{Altamura2013UnderstandingTP,
  title={Understanding the pharmacokinetics of anxiolytic drugs.},
  author={Alfredo Carlo Altamura and Donatella Moliterno and Silvia Paletta and Michele Maffini and Massimo Carlo Mauri and Silvio R Bareggi},
  journal={Expert opinion on drug metabolism & toxicology},
  year={2013},
  volume={9 4},
  pages={423-40}
}
INTRODUCTION Anxiety disorders are considered the most common mental disorders and they can increase the risk for comorbid mood and substance use disorders, significantly contributing to the global burden of disease. For this reason, anxiolytics are the most prescribed psychoactive drugs, particularly in the Western world. AREAS COVERED This review aims to analyze pharmacokinetic profile, plasma level variations so as the metabolism, interactions and possible relation to clinical effect of… CONTINUE READING
19 Extracted Citations
156 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 19 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 156 references

Manual of clinical psychopharmacology

  • AF Schatzberg, JO Cole, C. Debattista
  • edition. American Psychiatric Publishing,
  • 2010
Highly Influential
4 Excerpts

Buspirone -- an updated review of its clinical pharmacology and therapeutic applications

  • B Fulton, RN Brogden
  • CNS Drugs
  • 1997
Highly Influential
4 Excerpts

Clinical pharmacokinetics of beta-adrenoceptor blocking drugs

  • G Johnsson, Regardh C-G
  • Clin Pharmacokinet 1976;1:233-63
  • 1976
Highly Influential
6 Excerpts

Similar Papers

Loading similar papers…